Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 15/20 | 0.67 |
| ▸ | RET | P07949 | 2/20 | 0.43 |
| ▸ | CDK2 | P24941 | 2/20 | 0.43 |
| ▸ | GSK3B | P49841 | 2/20 | 0.43 |
| ▸ | ITK | Q08881 | 2/20 | 0.43 |
| ▸ | MERTK | Q12866 | 2/20 | 0.43 |
| ▸ | PRKAA1 | Q13131 | 2/20 | 0.43 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.43 |
| ▸ | MAP3K6 | O95382 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3486443 | 0.81 | MAP3K5 (0.79) | MAP3K5RETCDK2GSK3BITK | |
| SCHEMBL3486097 | 0.80 | MAP3K5 (1.00) | MAP3K5RETCDK2GSK3BITK | |
| Hydrochloric Acid SCHEMBL3486202 | 0.80 | MAP3K5 (0.77) | MAP3K5RETCDK2GSK3BITK | |
| SCHEMBL3486350 | 0.79 | MAP3K5 (0.84) | MAP3K5RETCDK2GSK3BITK | |
| SCHEMBL3486275 | 0.79 | MAP3K5 (0.76) | MAP3K5RETCDK2GSK3BITK | |
| SCHEMBL3485910 | 0.78 | MAP3K5 (0.77) | MAP3K5RETCDK2GSK3BITK | |
| SCHEMBL3486220 | 0.77 | MAP3K5 (0.80) | MAP3K5RETCDK2GSK3BITK | |
| SCHEMBL3485624 | 0.77 | MAP3K5 (0.65) | MAP3K5RETCDK2GSK3BITK | |
| SCHEMBL3486197 | 0.77 | MAP3K5 (0.65) | MAP3K5RETCDK2GSK3BITK | |
| SCHEMBL3486068 | 0.77 | MAP3K5 (0.65) | MAP3K5CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2058309-A1 | FUSED HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2009-05-13 | — | — | EP | disclosed |